Merck turns to Acclinate to increase African American participation in cancer trials

Against a backdrop of Big Pharma’s slow progress to increase the diversity of clinical trials, Merck & Co. has teamed up with digital health company Acclinate to try and enroll more African American patients in its cancer drug studies.